complement system

Japan Approvals The Use of Soliris (Eculizumab) Drug to Treat aHUS
Sep 17, 2013
Biotechnology firm Alexion Pharmaceuticals has secured approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the use of its Soliris (eculizumab) drug to treat pediatric and adult patients with atypical hemolytic ...

Tags: Ahus Treatment, Soliris Drug
Omeros Has Filed an Orphan Drug Application with The US FDA for OMS721
Apr 22, 2013
Omeros has filed an orphan drug application with the US FDA for OMS721, used to treat atypical hemolytic uremic syndrome (aHUS). OMS721 works by blocking the lectin pathway of the complement system while leaving intact the classical ...

Tags: Omeros, Orphan Drug, Medicine
Omeros Corporation Said That It Has Discovered The Proteins
Nov 28, 2012
Clinical-stage biopharmaceutical company Omeros Corporation said that it has discovered the proteins that activate the alternative pathway of the complement system as part of the company's mannan-binding lectin associated serine protease-2 ...

Tags: complement system, protease-2(MASP-2)program, pro-inflammatory protein